CELC
Price
$114.48
Change
+$10.27 (+9.86%)
Updated
Jan 14 closing price
Capitalization
5.3B
63 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$75.21
Change
+$1.08 (+1.46%)
Updated
Jan 14 closing price
Capitalization
6.01B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs KYMR

Header iconCELC vs KYMR Comparison
Open Charts CELC vs KYMRBanner chart's image
Celcuity
Price$114.48
Change+$10.27 (+9.86%)
Volume$504.41K
Capitalization5.3B
Kymera Therapeutics
Price$75.21
Change+$1.08 (+1.46%)
Volume$405.43K
Capitalization6.01B
CELC vs KYMR Comparison Chart in %
View a ticker or compare two or three
VS
CELC vs. KYMR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CELC: $114.48 vs. KYMR: $75.21)
Brand notoriety: CELC and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 58% vs. KYMR: 38%
Market capitalization -- CELC: $5.3B vs. KYMR: $6.01B
CELC [@Biotechnology] is valued at $5.3B. KYMR’s [@Biotechnology] market capitalization is $6.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CELC and KYMR are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а +4.86% price change this week, while KYMR (@Biotechnology) price change was -1.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CELC is expected to report earnings on Mar 19, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($6.02B) has a higher market cap than CELC($5.3B). CELC YTD gains are higher at: 14.778 vs. KYMR (-3.341). CELC has higher annual earnings (EBITDA): -148.31M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. CELC (455M). KYMR has less debt than CELC: KYMR (84M) vs CELC (320M). KYMR has higher revenues than CELC: KYMR (43.7M) vs CELC (0).
CELCKYMRCELC / KYMR
Capitalization5.3B6.02B88%
EBITDA-148.31M-286.52M52%
Gain YTD14.778-3.341-442%
P/E RatioN/AN/A-
Revenue043.7M-
Total Cash455M506M90%
Total Debt320M84M381%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
7
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCKYMR
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVQX30.200.27
+0.90%
JPMorgan Small Cap Value R4
CIBCX78.740.31
+0.40%
American Funds Capital Income Bldr C
JIGCX59.090.09
+0.15%
Janus Henderson Overseas C
IMIDX19.94-0.09
-0.45%
Congress Mid Cap Growth Institutional
IGIAX115.77-0.65
-0.56%
Integrity Growth & Income Fund A

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+9.86%
IMA - CELC
80%
Closely correlated
+0.89%
NEVPF - CELC
61%
Loosely correlated
N/A
SLXN - CELC
53%
Loosely correlated
+0.47%
ABOS - CELC
44%
Loosely correlated
+3.47%
KYMR - CELC
42%
Loosely correlated
+1.46%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+1.46%
NRIX - KYMR
65%
Loosely correlated
+0.58%
WVE - KYMR
54%
Loosely correlated
+2.04%
VERA - KYMR
53%
Loosely correlated
-1.41%
OCUL - KYMR
52%
Loosely correlated
+6.14%
GPCR - KYMR
50%
Loosely correlated
+8.23%
More